Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000312069-25-000100
Filing Date
2025-02-07
Accepted
2025-02-07 16:34:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 3992
  Complete submission text file 0000312069-25-000100.txt   6052
Mailing Address 1 CHURCHILL PLACE CANARY WHARF LONDON X0 E14 5HP
Business Address 1 CHURCHILL PLACE CANARY WHARF LONDON X0 E14 5HP 00442031340952
BARCLAYS PLC (Filed by) CIK: 0000312069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6029 Commercial Banks, NEC
(CF Office: 02 Finance)

Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Subject) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89656 | Film No.: 25602388
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)